FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact

被引：0

作者：

Marianne Vogsen

Jeanette Dupont Jensen

Ivar Yannick Christensen

Oke Gerke

Anne Marie Bak Jylling

Lisbet Brønsro Larsen

Poul-Erik Braad

Katrine Lydolph Søe

Camilla Bille

Marianne Ewertz

Malene Grubbe Hildebrandt

机构：

[1] Odense University Hospital,Department of Oncology

[2] Odense University Hospital,Department of Nuclear Medicine

[3] University of Southern Denmark,Department of Clinical Research

[4] Odense University Hospital,Odense Patient Data Explorative Network

[5] Odense University Hospital,Centre for Personalized Response Monitoring in Oncology (PREMIO)

[6] Odense University Hospital,Department of Radiology

[7] Odense University Hospital,Department of Pathology

[8] Odense University Hospital,Department of Breast Surgery

[9] Odense University Hospital,Department of Plastic Surgery

[10] Odense University Hospital,Centre for Innovative Medical Technology

[11] Odense University Hospital,Department of Oncology and Department of Nuclear Medicine

来源：

Breast Cancer Research and Treatment | 2021年 / 185卷

关键词：

Breast cancer; FDG-PET/CT; Stage migration; Clinical impact; Incidental findings;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：145 / 153

页数：8

共 50 条

[1] FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact
Vogsen, Marianne
Jensen, Jeanette Dupont
Christensen, Ivar Yannick
Gerke, Oke
Jylling, Anne Marie Bak
Larsen, Lisbet Bronsro
Braad, Poul-Erik
Soe, Katrine Lydolph
Bille, Camilla
Ewertz, Marianne
Hildebrandt, Malene Grubbe
BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 145 - 153
[2] Male primary breast cancer found on FDG-PET/CT
McEachen, James C.
Kuo, Phillip H.
CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 630 - 632
[3] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
Na Young Jung
Ie Ryung Yoo
Bong Joo Kang
Sung Hun Kim
Byung Joo Chae
Ye Young Seo
Breast Cancer, 2016, 23 : 141 - 148
[4] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
Jung, Na Young
Yoo, Ie Ryung
Kang, Bong Joo
Kim, Sung Hun
Chae, Byung Joo
Seo, Ye Young
BREAST CANCER, 2016, 23 (01) : 141 - 148
[5] FDG-PET and PET/CT in breast cancer staging
Avril, Norbert
Mather, Stephen J.
Roylance, Rebecca
BREAST CARE, 2007, 2 (06) : 372 - 377
[6] Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
Vogsen, Marianne
Jensen, Jeanette Dupont
Gerke, Oke
Jylling, Anne Marie Bak
Asmussen, Jon Thor
Christensen, Ivar Yannick
Braad, Poul-Erik
Thye-Ronn, Peter
Soe, Katrine Lydolph
Ewertz, Marianne
Hildebrandt, Malene Grubbe
EJNMMI RESEARCH, 2021, 11 (01)
[7] Clinical impact of FDG-PET/CT on colorectal cancer staging and treatment strategy
Petersen, Rasmus K.
Hess, Soren
Alavi, Abass
Hoilund-Carlsen, Poul F.
AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 4 (05):
[8] The clinical utility of FDG-PET/CT in follow up and restaging of breast cancer patients
Emad-Eldin, Sally
Abdelaziz, Omar
Harth, Marc
Hussein, Manar
Nour-Eldin, Nour-Eldin
Vogl, Thomas J.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2013, 44 (04) : 937 - 943
[9] Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
Naghavi-Behzad, Mohammad
Oltmann, Hjalte Rasmus
Alamdari, Tural Asgharzadeh
Bulow, Jakob Lykke
Ljungstrom, Lasse
Braad, Poul-Erik
Asmussen, Jon Thor
Vogsen, Marianne
Kodahl, Annette Raskov
Gerke, Oke
Hildebrandt, Malene Grubbe
CANCERS, 2021, 13 (16)
[10] FDG-PET/CT in the diagnosis of recurrent breast cancer
Murakami, Ryusuke
Kumita, Shin-ichiro
Yoshida, Tamiko
Ishihara, Keiichi
Kiriyama, Tomonari
Hakozaki, Kenta
Yanagihara, Keiko
Iida, Shinya
Tsuchiya, Shin-ichi
ACTA RADIOLOGICA, 2012, 53 (01) : 12 - 16

← 1 2 3 4 5 →